Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience cash
Cash and short-term investments held at the end of each period.
Harvard Bioscience's cash was $6.50M at Jun 30, 2026. For fiscal 2025 it was $8.61M, up 109.7% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $25.77M in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.61M | +109.7% |
| FY2024 | Dec 31, 2024 | $4.11M | -4.1% |
| FY2023 | Dec 31, 2023 | $4.28M | -5.0% |
| FY2022 | Dec 31, 2022 | $4.51M | -42.4% |
| FY2021 | Dec 31, 2021 | $7.82M | -6.0% |
| FY2020 | Dec 31, 2020 | $8.32M | -0.2% |
| FY2019 | Dec 31, 2019 | $8.34M | +2.0% |
| FY2018 | Dec 31, 2018 | $8.17M | +42.6% |
| FY2017 | Dec 31, 2017 | $5.73M | +2.4% |
| FY2016 | Dec 31, 2016 | $5.60M | -17.0% |
| FY2015 | Dec 31, 2015 | $6.74M | -52.3% |
| FY2014 | Dec 31, 2014 | $14.13M | -45.2% |
| FY2013 | Dec 31, 2013 | $25.77M | +24.6% |
| FY2012 | Dec 31, 2012 | $20.68M | +15.4% |
| FY2011 | Dec 31, 2011 | $17.92M | -9.1% |
| FY2010 | Dec 31, 2010 | $19.70M | +18.8% |
| FY2009 | Dec 31, 2009 | $16.59M | +21.1% |
| FY2008 | Dec 31, 2008 | $13.70M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.50M | -12.6% |
| Q1 FY2026 | Mar 31, 2026 | $7.10M | +28.0% |
| Q4 FY2025 | Dec 31, 2025 | $8.61M | +109.7% |
| Q3 FY2025 | Sep 30, 2025 | $6.82M | +49.2% |
| Q2 FY2025 | Jun 30, 2025 | $7.44M | +83.8% |
| Q1 FY2025 | Mar 31, 2025 | $5.55M | +30.3% |
| Q4 FY2024 | Dec 31, 2024 | $4.11M | -4.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.57M | -14.4% |
| Q2 FY2024 | Jun 30, 2024 | $4.05M | -6.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.26M | +12.3% |
| Q4 FY2023 | Dec 31, 2023 | $4.28M | -5.0% |
| Q3 FY2023 | Sep 30, 2023 | $5.34M | +3.8% |
| Q2 FY2023 | Jun 30, 2023 | $4.32M | +1.5% |
| Q1 FY2023 | Mar 31, 2023 | $3.79M | -30.3% |
| Q4 FY2022 | Dec 31, 2022 | $4.51M | -42.4% |
| Q3 FY2022 | Sep 30, 2022 | $5.14M | -7.3% |
| Q2 FY2022 | Jun 30, 2022 | $4.26M | -31.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.43M | -6.6% |
| Q4 FY2021 | Dec 31, 2021 | $7.82M | -6.0% |
| Q3 FY2021 | Sep 30, 2021 | $5.55M | +97.7% |
| Q2 FY2021 | Jun 30, 2021 | $6.24M | +137.2% |
| Q1 FY2021 | Mar 31, 2021 | $5.82M | -1.1% |
| Q4 FY2020 | Dec 31, 2020 | $8.32M | -0.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.81M | -59.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.63M | -46.7% |
| Q1 FY2020 | Mar 31, 2020 | $5.88M | +16.9% |
| Q4 FY2019 | Dec 31, 2019 | $8.34M | +2.0% |
| Q3 FY2019 | Sep 30, 2019 | $6.85M | +2.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.93M | -12.3% |
| Q1 FY2019 | Mar 31, 2019 | $5.03M | -16.0% |
| Q4 FY2018 | Dec 31, 2018 | $8.17M | +42.6% |
| Q3 FY2018 | Sep 30, 2018 | $6.66M | +14.1% |
| Q2 FY2018 | Jun 30, 2018 | $5.62M | +19.1% |
| Q1 FY2018 | Mar 31, 2018 | $5.99M | +30.3% |
| Q4 FY2017 | Dec 31, 2017 | $5.73M | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $5.84M | +9.2% |
| Q2 FY2017 | Jun 30, 2017 | $4.72M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.60M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.60M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.35M | – |
See a number that looks wrong?